earnings
confidence high
sentiment positive
materiality 0.80
Waters Q3 sales $800M (+8% YoY), non-GAAP EPS $3.40 (+16%), raises FY guidance
WATERS CORP /DE/
2025-FY EPS reported
$2.50
revenue$799,887,000
- Sales $800M, +8% as reported and constant currency, above guidance.
- GAAP EPS $2.50; non-GAAP EPS $3.40, up 16% YoY, above guidance.
- Pharma +11% cc; instruments +6%, recurring +9% cc; chemistry double-digit growth.
- FY25 constant currency sales growth guidance raised to +6.7% to +7.3%; non-GAAP EPS raised to $13.05-$13.15.
- Integration planning for BD Biosciences acquisition progressing; CEO confident in synergies.